Blog - Page 3425 of 5493

FridayDec 10, 2010 3:01 pm

NewCardio, Inc. (NWCI.OB) Announces Positive Results from Cardiac Safety Research Consortium

NewCardio Inc. is a cardiac diagnostic and services company developing and marketing proprietary software technologies for the monitoring and diagnosis of cardiovascular disease, as well as cardiac safety assessment of drugs under development. The company today announced results from a blinded drug safety study conducted by the Cardiac Safety Research Consortium (CSRC) to evaluate the performance of QTinno™ on its "testing" ECG dataset. QTinno is New Cardio’s patented software technology used to assess drug cardiac toxicity in drug development. The CSRC study results demonstrate QTinno’s ability to accurately detect the control drug’s (moxifloxacin)-induced QT interval prolongation, as well as its…

FridayDec 10, 2010 2:31 pm

Endeavor Power Corp. (EDVP.OB) is “One to Watch”

Endeavor Power Corp. is a full-service e-waste recovery company that trades on the OTC Bulletin Board. Aiming their processing services at industrial and government clients, the company has the logistical capability to purchase and transport product all over North America. Endeavor Power Corporation has their corporate headquarters in Robesonia, Pennsylvania. The Company is staffed by a team of professionals, both inside the company and outside as independent contractors and consultants. Endeavor approaches each new project using their own established and proprietary pricing methods and their unbending commitment to environmental protection. Electronic waste is quickly becoming the fastest growing waste stream…

FridayDec 10, 2010 2:19 pm

Medistem, Inc. (MEDS.PK) Shares Up Big on Stem Cell News

Medistem, Inc.'s stock is soaring today after the company released news of a peer-reviewed publication on its data for what the company believes is the world’s first “combination therapy” human stem cell protocol for a spinal cord injury. San Diego, California-based Medistem is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The Company has filed an Investigational New Drug (IND) application with the FDA for use of its universal donor endometrial regenerative cells (ERC) for treatment of critical limb ischemia, an advanced form of peripheral artery disease. Medistem…

FridayDec 10, 2010 2:14 pm

Beacon Equity Research: Amico Games Corp. (AMCG.OB)

Amico Games is a subscriber-based developer of interactive gaming which leverages Java™ technology and China’s 3G network infrastructure to deliver some of the hottest massively multiplayer online role playing games (MMORPG) and online games available. With a registered user base exceeding 29M, AMCG is an established player in the Chinese gaming space. The Company pioneered some of the earliest mobile phone games, partnering with major industry player Nokia to offer interactive gaming over China Mobile’s WAP platform. The MMORPG sector is arguably the most exciting area of online gaming as it attracts long-term customer relationships. Users pay a recurring monthly…

FridayDec 10, 2010 2:07 pm

Crimson Exploration Inc. (CXPO) Reports on Bossier Development Program in Texas

Crimson Exploration Inc. issued an operational update on its oil and gas activities in the United States, where the company is working to explore and develop the Bossier formation. Crimson Exploration Inc. reported the completion of the Gobi #1 H well at the Bruin Prospect area. The well was drilled to a total measured depth of approximately 18,000 feet, and initial production was reported at 11.7 million cubic feet of natural gas per day. The Gobi #1 H well is located in San Augustine, County, Texas, and Crimson Exploration Inc. has a 70% working interest. Crimson Exploration Inc. reported that…

FridayDec 10, 2010 2:05 pm

Titan Oil & Gas, Inc. (TNGS.OB) is “One to Watch”

Titan Oil & Gas, Inc. is an oil & gas company aggressively exploring and acquiring land in key petroleum-producing regions of Alberta, Canada. The Company’s projects are in areas of excellent infrastructure and high drilling activity. They plan on using the most current and proven cost effective technologies to generate long-term reserves and production while maximizing shareholder value. Alberta is one of the most prolific regions for oil exploration and production in the world. The province contains an estimated 174 billion barrels of oil. This represents more than 8-times the reserves of the entire United States. Alberta also hosts significant…

FridayDec 10, 2010 2:01 pm

Ardent Mines Ltd. (ADNT.OB) Announces Two Key Appointments to Board Ahead of 2011 Mining Acquisitions and Uplisting

Ardent Mines, an exploration stage mineral developer in the process of resource acquisition and logistical infrastructure assembly, reported the appointments of two new members to the Company’s Board of Directors today, Mr. James Ladner and Mr. Luciano De Freitas Borges. CEO of ADNT, Leonardo Riera, took a moment to comment on the appointment of these two remarkable gentlemen, even characterizing the decision as a milestone for ADNT itself, due to the vast experiential knowledge and industry experience possessed by both. Riera went on to indicate that 2011 should see the close of several major mining acquisitions, a listing of ADNT…

FridayDec 10, 2010 12:44 pm

AgFeed Industries, Inc. (FEED) Video Chart for Friday, December 10, 2010

After a gap down in November, FEED is establishing a higher low and a base in the area of $2.40. Technical traders are on alert for the base to hold with an increase in buying pressure to push the stock north of the 20 day moving average. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

FridayDec 10, 2010 12:17 pm

Fast Moving Approval of Food Safety Bill Seen as Boost for Micro Identification Technologies, Inc. (MMTC.OB)

When some of the biggest companies in the food industry started lining up in support of food safety legislation that is now going through Congress, it helped ensure uncharacteristically rapid progress, and was lauded by consumer groups as a solid step in the right direction. Skeptics were quick to point out, however, that the latest version of the bill would do little to affect procedures for these larger companies, and would simply put increased pressure on their smaller competitors to get up to speed. Nevertheless, it’s seen as a win for the American public in the face of a string…

FridayDec 10, 2010 12:13 pm

Arena Pharmaceuticals, Inc. (ARNA) Begins Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension

Arena Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral drugs that target G protein-coupled receptors in four major therapeutic areas. These areas are cardiovascular, central nervous system, inflammatory and metabolic diseases. The company announced today the initiation of dosing in a Phase 1 clinical trial of APD811, a novel oral drug candidate discovered by Arena that targets the prostacyclin receptor for the treatment of pulmonary arterial hypertension or PAH. The Phase 1 trial is planned to enroll up to 72 healthy adult volunteers and will evaluate the safety, tolerability and pharmacokinetics of single-ascending doses of…

Site Search

Company Search